Terms: = Lung cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
20 results:
1. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
2. Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada.
Grafham GK; Craddock KJ; Huang WY; Louie AV; Zhang L; Hwang DM; Parmar A
Cancer Med; 2024 Feb; 13(3):e6886. PubMed ID: 38317584
[TBL] [Abstract] [Full Text] [Related]
3. Impact of rapid on-site evaluation in expediting the fast investigative lung cancer pathway.
Fowell A; Khan K
Cytopathology; 2024 Mar; 35(2):250-255. PubMed ID: 38054566
[TBL] [Abstract] [Full Text] [Related]
4. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
[TBL] [Abstract] [Full Text] [Related]
5. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
[TBL] [Abstract] [Full Text] [Related]
6. Fast investigative lung cancer pathway and endobronchial ultrasound procedure supported by rapid on-site evaluation.
Khan KA; Narine N; Bailey S; Shelton D; Rana D
Diagn Cytopathol; 2022 Sep; 50(9):436-441. PubMed ID: 35808981
[TBL] [Abstract] [Full Text] [Related]
7. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell lung cancer: Outcome and Safety in the Real World: FLOWER Study.
Lorenzi M; Ferro A; Cecere F; Scattolin D; Del Conte A; Follador A; Pilotto S; Polo V; Santarpia M; Chiari R; Pavan A; Dal Maso A; Da Ros V; Targato G; Vari S; Indraccolo S; Calabrese F; Frega S; Bonanno L; Conte PF; Guarneri V; Pasello G
Oncologist; 2022 Mar; 27(2):87-e115. PubMed ID: 35641222
[TBL] [Abstract] [Full Text] [Related]
8. Clinical response of carboplatin-based chemotherapy and its association to genetic polymorphism in lung cancer patients from North India - A clinical pharmacogenomics study.
Ritambhara ; Tiwari S; Vijayaraghavalu S; Siddiqui MA; Al-Khedhairy AA; Kumar M
J Cancer Res Ther; 2022; 18(1):109-118. PubMed ID: 35381771
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell lung cancer (aNSCLC) Using Real-World Electronic Health Record Data.
John A; Yang B; Shah R
Adv Ther; 2021 Mar; 38(3):1552-1566. PubMed ID: 33537872
[TBL] [Abstract] [Full Text] [Related]
10. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
Hegde A; Andreev-Drakhlin AY; Roszik J; Huang L; Liu S; Hess K; Cabanillas M; Hu MI; Busaidy NL; Sherman SI; Dadu R; Grubbs EG; Ali SM; Lee J; Elamin YY; Simon GR; Blumenschein GR; Papadimitrakopoulou VA; Hong D; Meric-Bernstam F; Heymach J; Subbiah V
ESMO Open; 2020 Oct; 5(5):e000799. PubMed ID: 33097651
[TBL] [Abstract] [Full Text] [Related]
11. Timing of treatment in small-cell lung cancer.
Bhandari S; Pham D; Pinkston C; Oechsli M; Kloecker G
Med Oncol; 2019 Apr; 36(6):47. PubMed ID: 31025131
[TBL] [Abstract] [Full Text] [Related]
12. Nocardiosis: 7-year experience at an Australian tertiary hospital.
Paige EK; Spelman D
Intern Med J; 2019 Mar; 49(3):373-379. PubMed ID: 30091232
[TBL] [Abstract] [Full Text] [Related]
13. The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.
Sonavane SK; Pinsky P; Watts J; Gierada DS; Munden R; Singh SP; Nath H
Eur Radiol; 2017 Dec; 27(12):5113-5118. PubMed ID: 28616728
[TBL] [Abstract] [Full Text] [Related]
14. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract] [Full Text] [Related]
15. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
16. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell lung cancer Survival.
Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
[TBL] [Abstract] [Full Text] [Related]
17. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care.
Riedel RF; Wang X; McCormack M; Toloza E; Montana GS; Schreiber G; Kelley MJ
J Thorac Oncol; 2006 Sep; 1(7):692-6. PubMed ID: 17409938
[TBL] [Abstract] [Full Text] [Related]
18. The DNA repair gene ercc2/xpd polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.
Yin J; Li J; Ma Y; Guo L; Wang H; Vogel U
Cancer Lett; 2005 Jun; 223(2):219-26. PubMed ID: 15896456
[TBL] [Abstract] [Full Text] [Related]
19. State of the art in thoracospic surgery: a personal experience of 2000 videothoracoscopic procedures and an overview of the literature.
Roviaro GC; Varoli F; Vergani C; Maciocco M
Surg Endosc; 2002 Jun; 16(6):881-92. PubMed ID: 12163949
[TBL] [Abstract] [Full Text] [Related]
20. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire cancer Registry.
Seddon DJ; Williams EM
Br J Cancer; 1997; 76(5):667-74. PubMed ID: 9303369
[TBL] [Abstract] [Full Text] [Related]
